A program run by Vanderbilt University Medical Center that provides peer feedback to high-risk clinicians was associated with a significant decrease in malpractice claims costs at a large orthopaedic surgery practice, according to a recent study.

The long-standing partnership between Vanderbilt Institute for Global Health (VIGH) and collaborators Aminu Kano Teaching Hospital (AKTH) and Bayero University (BUK) is poised to address the growing demand for research in precision medicine in Africa.

At present, 44 countries, including the European Union, have banned or are phasing out atrazine due to concern for its negative effects on human health.

Developed in a region with the world’s highest HIV prevalence, this study design and intervention has the potential to impact testing uptake among a “hidden population” by mobilizing trained healers, who vastly outnumber allopathic care providers in South Africa.

In a national retrospective study led by researchers at Vanderbilt University School of Medicine, diltiazem, when given in combination with the anticoagulant drugs apixaban (Eliquis) or rivaroxaban (Xarelto), significantly increased the risk of serious bleeding compared to metoprolol.

Infectious diseases researcher H. Keipp Talbot, MD, MPH, has been appointed chair of the Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention.

This year’s Vanderbilt Child Health Poll shows that over 40% of Tennessee families report they are food insecure ― a similar proportion from last year. Most families (71%) say they have continued to change food spending habits due to high prices.